Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches ...
The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic ...
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...
A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.
Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...
Times-Review, a CNHI newspaper. It does not necessarily reflect the opinion of The Tribune- Democrat. Forty percent of Americans are said to be obese. This has been going on for some time. Cheap ...
A survey of 1,000 women, aged 30 to 75, found most were considering taking the likes of Wegovy and Mounjaro to help them lose ...
On Tuesday, New York Governor Kathy Hochul announced a new initiative to expand access to healthcare coverage for popular ...
Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...
Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13, according to a Wall Street Journal report.
With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...